LifeNet Health and Johnson & Johnson MedTech launched the PliaFX Flo demineralized bone matrix.

SurGenTec earned FDA 510(k) clearance for its OsteoFlo HydroFiber to be used as a stand-alone equivalent to autografts in spine surgeries.

Royal Biologics and Fair Winds Medical partnered to distribute spine and orthopedic biologics, according to a Jan. 16 news release.

From new studies and milestones, here are seven key updates in orthobiologics since Nov. 13.

Ventris Medical earned FDA 510(k) clearance for its Backpack bone graft containment system, according to a Jan. 9 news release. 

Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology. 

Orthobiologics piqued the interest of spine surgeons and Becker's readers in 2024. Here are four key conversations.

Durham, N.C.-based Duke University has won a $3.9 million grant to study gender differences in ACL injuries, according to a Dec. 20 report from WRAL News.

Columbus, Ohio-based Atreon Orthopedics has completed 10,000 rotator cuff repair surgeries with the use of its Rotium bioresorbable wick. 

RTI Surgical, a contract development and manufacturing organization for regenerative medicine, rebranded to Evergen.

A clinical trial out of the University of California San Diego School of Medicine found that neural stem cell transplantation had shown long-term safety and feasibility for treating chronic spinal cord injuries.

Theradaptive earned the FDA's investigational device exemption approval to broaden its clinical research for the OsteoAdapt SP implant, the company said Dec. 10.

Three-year data for the Discseel spine procedure found it was effective and could replace most spine surgeries, Discseel Technologies said Dec. 4. 

Bioretec signed a distribution agreement to accelerate commercialization of the RemeOs trauma screw system in the U.S., according to a Nov. 22 news release. 

From company acquisitions to FDA nods, here are six key updates in orthobiologics since Oct. 4.

Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler, the company said Nov. 12.

Biologics company Theradaptive's lead therapeutic, OsteoAdapt SP, has been featured in a preclinical spinal fusion study published in Spine, a prominent, peer-reviewed publication for spinal surgeons.

Spine biologics holds incredible potential if it can overcome obstacles related to disc anatomy, Ezriel Kornel, MD, said. 

CytexOrtho has earned FDA approval to begin a clinical trial evaluating the safety and efficacy of its absorbable hip implant in human patients, according to an Oct. 29 report from Mass Device.

Washington, D.C.-based Regenerative Orthopedics & Sports Medicine has partnered with the Orthobiologics Research Initiative to support nonsurgical orthopedic research aimed at treating partial-thickness rotator cuff tears using cutting-edge orthobiologic procedures.